• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在仔猪组织笼模型中对头孢喹肟针对大肠杆菌的突变选择窗进行体内评估。

In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.

作者信息

Zhang Bingxu, Gu Xiaoyan, Li Yafei, Li Xiaohong, Gu Mengxiao, Zhang Nan, Shen Xiangguang, Ding Huanzhong

机构信息

National Reference Laboratory of Veterinary Drug Residues (SCAU), College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.

出版信息

BMC Vet Res. 2014 Dec 16;10:297. doi: 10.1186/s12917-014-0297-1.

DOI:10.1186/s12917-014-0297-1
PMID:25511985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4279896/
Abstract

BACKGROUND

The resistance of cephalosporins is significantly serious in veterinary clinic. In order to inhibit the bacterial resistance production, the mutant selection window (MSW) hypothesis with Escherichia coli (E. coli) ATCC 25922 exposed to cefquinome in an animal tissue-cage model was investigated.

RESULTS

Localized infection with E. coli was established in piglets, and the infected animals were administrated intramuscularly with various doses and intervals of cefquinome to provide antibiotic concentrations below the MIC99, between the MIC99 and the mutant prevention concentration (MPC), and above the MPC. E. coli lost susceptibility when drug concentrations fluctuated between the lower and upper boundaries of the window, which defined in vitro as the MIC99 (0.06 μg/mL) and the MPC (0.16 μg/mL) respectively. For PK/PD parameters, there were no mutant selection enrichment when T>MIC99 was ≤ 25% or T>MPC was ≥ 50% of administration interval. When T>MIC99 was > 25% and T>MPC was <50% of administration interval, resistance selection was observed. When AUC24 h/MIC99 and AUC24 h/MPC were considered, the mutant selection window extended from 32.84 h to 125.64 h and from 12.83 h to 49.09 h, respectively.

CONCLUSIONS

These findings demonstrate that the MSW exists in vivo for time-dependent antimicrobial agents, and its boundaries fit well with those determined in vitro. Maintenance of antimicrobial concentrations above the MPC for > 50% of administration interval is a straightforward way to restrict the acquisition of resistance in this tissue cage model. This situation was achieved with daily intramuscular doses of 1 mg cefquinome/kg body weight.

摘要

背景

头孢菌素类药物在兽医临床中的耐药性问题十分严重。为了抑制细菌耐药性的产生,我们在动物组织笼模型中,以大肠杆菌(E. coli)ATCC 25922为研究对象,探讨了头孢喹肟的突变选择窗(MSW)假说。

结果

在仔猪中建立了大肠杆菌局部感染模型,对感染动物肌肉注射不同剂量和给药间隔的头孢喹肟,使抗生素浓度分别低于MIC99、介于MIC99与突变预防浓度(MPC)之间以及高于MPC。当药物浓度在体外定义的窗口下限和上限之间波动时,大肠杆菌失去敏感性,该窗口下限和上限分别为MIC99(0.06μg/mL)和MPC(0.16μg/mL)。对于药代动力学/药效学(PK/PD)参数,当给药间隔中T>MIC99≤25%或T>MPC≥50%时,未观察到突变选择富集。当给药间隔中T>MIC99>25%且T>MPC<50%时,观察到耐药性选择。当考虑AUC24 h/MIC99和AUC24 h/MPC时,突变选择窗分别从32.84小时扩展到125.64小时和从12.83小时扩展到49.09小时。

结论

这些研究结果表明,对于时间依赖性抗菌药物,体内存在突变选择窗,其边界与体外测定的边界吻合良好。在给药间隔的>50%时间内维持抗菌药物浓度高于MPC是在该组织笼模型中限制耐药性产生的一种直接方法。每日肌肉注射1mg/kg体重的头孢喹肟可实现这种情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9358/4279896/57fe505c214d/12917_2014_297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9358/4279896/542d7af3ac76/12917_2014_297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9358/4279896/4e1618ac74a8/12917_2014_297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9358/4279896/57fe505c214d/12917_2014_297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9358/4279896/542d7af3ac76/12917_2014_297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9358/4279896/4e1618ac74a8/12917_2014_297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9358/4279896/57fe505c214d/12917_2014_297_Fig3_HTML.jpg

相似文献

1
In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.在仔猪组织笼模型中对头孢喹肟针对大肠杆菌的突变选择窗进行体内评估。
BMC Vet Res. 2014 Dec 16;10:297. doi: 10.1186/s12917-014-0297-1.
2
Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.一株临床大肠杆菌菌株在仔猪组织笼模型中对反复接触头孢喹肟的反应。
BMC Vet Res. 2015 Jul 25;11:169. doi: 10.1186/s12917-015-0486-6.
3
Testing the mutant selection window hypothesis with Escherichia coli exposed to levofloxacin in a rabbit tissue cage infection model.在兔组织笼感染模型中,用暴露于左氧氟沙星的大肠杆菌检验突变选择窗假说。
Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):385-9. doi: 10.1007/s10096-013-1968-8. Epub 2013 Sep 14.
4
Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model.头孢喹肟在兔组织笼感染模型中的药代动力学/药效学参数与金黄色葡萄球菌耐药性产生的关系
Front Microbiol. 2016 Jun 7;7:874. doi: 10.3389/fmicb.2016.00874. eCollection 2016.
5
Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.用磷霉素验证针对大肠杆菌和铜绿假单胞菌的突变选择窗假说:一项体外和体内比较研究。
J Antibiot (Tokyo). 2017 Feb;70(2):166-173. doi: 10.1038/ja.2016.124. Epub 2016 Oct 19.
6
The mutant selection window in rabbits infected with Staphylococcus aureus.感染金黄色葡萄球菌的兔子体内的突变选择窗。
J Infect Dis. 2006 Dec 1;194(11):1601-8. doi: 10.1086/508752. Epub 2006 Oct 20.
7
In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.四种抗菌药物对鸭疫里默氏菌分离株的体外敏感性:头孢噻呋、头孢喹肟、氟苯尼考和替米考星的最低抑菌浓度与突变预防浓度比较
BMC Vet Res. 2016 Nov 9;12(1):250. doi: 10.1186/s12917-016-0796-3.
8
Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.在体外动态模型中,用暴露于达托霉素和万古霉素的金黄色葡萄球菌检验突变选择窗假说。
J Antimicrob Chemother. 2006 Dec;58(6):1185-92. doi: 10.1093/jac/dkl387. Epub 2006 Oct 5.
9
Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin.检测感染耐甲氧西林金黄色葡萄球菌的兔子在接触万古霉素时的突变选择窗。
J Antimicrob Chemother. 2012 Nov;67(11):2700-6. doi: 10.1093/jac/dks280. Epub 2012 Jul 18.
10
Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids.头孢喹肟在猪血清和组织笼液中的药代动力学及体外药效学
Vet J. 2014 Mar;199(3):399-405. doi: 10.1016/j.tvjl.2013.12.015. Epub 2013 Dec 16.

引用本文的文献

1
Pharmacokinetic and pharmacodynamic integration and resistance analysis of cefquinome against dynamic model.头孢喹肟对动态模型的药代动力学与药效学整合及耐药性分析
Front Microbiol. 2025 Jul 23;16:1533892. doi: 10.3389/fmicb.2025.1533892. eCollection 2025.
2
Susceptibility evaluation and PK/PD integration of tulathromycin against during the mutant selection window.在突变选择窗期间,泰拉霉素的敏感性评估及药代动力学/药效学整合
Front Vet Sci. 2024 Jul 3;11:1407907. doi: 10.3389/fvets.2024.1407907. eCollection 2024.
3
Evaluation the kill rate and mutant selection window of danofloxacin against Actinobacillus pleuropneumoniae in a peristaltic pump model.

本文引用的文献

1
Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin.检测感染耐甲氧西林金黄色葡萄球菌的兔子在接触万古霉素时的突变选择窗。
J Antimicrob Chemother. 2012 Nov;67(11):2700-6. doi: 10.1093/jac/dks280. Epub 2012 Jul 18.
2
Mutant prevention concentration-based pharmacokinetic/pharmacodynamic indices as dosing targets for suppressing the enrichment of levofloxacin-resistant subpopulations of Staphylococcus aureus.基于突变预防浓度的药代动力学/药效学指标作为抑制金黄色葡萄球菌左氧氟沙星耐药亚群富集的给药目标。
Antimicrob Agents Chemother. 2011 May;55(5):2409-12. doi: 10.1128/AAC.00975-10. Epub 2011 Feb 22.
3
评价在蠕动泵模型中丹氟沙星对胸膜肺炎放线杆菌的杀菌率和突变选择窗。
BMC Vet Res. 2024 Jun 3;20(1):241. doi: 10.1186/s12917-024-04016-9.
4
Comparative Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and Seven Other Antimicrobial Agents Tested against Bovine Isolates of and .针对从牛身上分离出的[具体细菌名称未给出],对普拉德氟沙星及其他七种抗菌剂进行比较的最低抑菌浓度和突变预防浓度。
Pathogens. 2024 May 9;13(5):399. doi: 10.3390/pathogens13050399.
5
Evaluation of the mutant selection window of danofloxacin against in an dynamic model.在动态模型中对达氟沙星针对[具体对象]的突变选择窗的评估。 (注:原文中“in an dynamic model”中间少了个单词,推测可能是“in an in vitro dynamic model”之类的表述,这里按有缺失的原文翻译)
Front Vet Sci. 2023 Jan 30;10:1107608. doi: 10.3389/fvets.2023.1107608. eCollection 2023.
6
Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement.氟喹诺酮类药物异质性耐药、抗菌药物耐受性和致死率增强。
Front Cell Infect Microbiol. 2022 Sep 29;12:938032. doi: 10.3389/fcimb.2022.938032. eCollection 2022.
7
Pharmacokinetic/Pharmacodynamic Relationships of Tulathromycin Against in a Porcine Tissue Cage Infection Model.在猪组织笼感染模型中,图拉霉素的药代动力学/药效学关系
Front Vet Sci. 2022 Mar 28;9:822432. doi: 10.3389/fvets.2022.822432. eCollection 2022.
8
Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models.药代动力学/药效学(PK/PD)整合模型的药效学参数
Front Vet Sci. 2022 Mar 24;9:860472. doi: 10.3389/fvets.2022.860472. eCollection 2022.
9
Disposition of Cefquinome in Turkeys () Following Intravenous and Intramuscular Administration.头孢喹肟在火鸡体内静脉注射和肌肉注射后的处置情况
Pharmaceutics. 2021 Oct 28;13(11):1804. doi: 10.3390/pharmaceutics13111804.
10
Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against .小鼠大腿微透析法评估头孢喹肟的药代动力学/药效学整合情况 针对……
Front Vet Sci. 2020 Aug 5;7:448. doi: 10.3389/fvets.2020.00448. eCollection 2020.
New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.
抗菌药物敏感性试验的新概念:突变预防浓度和突变选择窗方法。
Vet Dermatol. 2009 Oct;20(5-6):383-96. doi: 10.1111/j.1365-3164.2009.00856.x.
4
Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model.在小鼠大腿细菌感染模型中,对接种量对喹诺酮类药物在大肠杆菌中耐药性选择的影响进行药代动力学/药效学分析。
Antimicrob Agents Chemother. 2009 Aug;53(8):3384-90. doi: 10.1128/AAC.01347-08. Epub 2009 Jun 1.
5
Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline.体外动态模型中耐利奈唑胺屎肠球菌的选择:多西环素的保护作用
J Antimicrob Chemother. 2008 Mar;61(3):629-35. doi: 10.1093/jac/dkm542. Epub 2008 Feb 1.
6
Mutant selection window hypothesis updated.突变选择窗假说更新。
Clin Infect Dis. 2007 Mar 1;44(5):681-8. doi: 10.1086/511642. Epub 2007 Jan 24.
7
The mutant selection window in rabbits infected with Staphylococcus aureus.感染金黄色葡萄球菌的兔子体内的突变选择窗。
J Infect Dis. 2006 Dec 1;194(11):1601-8. doi: 10.1086/508752. Epub 2006 Oct 20.
8
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update.抗感染药物药代动力学/药效学(PK/PD)术语的标准化:更新版
J Antimicrob Chemother. 2005 May;55(5):601-7. doi: 10.1093/jac/dki079. Epub 2005 Mar 16.
9
Antibacterial resistance worldwide: causes, challenges and responses.全球抗菌药物耐药性:原因、挑战及应对措施
Nat Med. 2004 Dec;10(12 Suppl):S122-9. doi: 10.1038/nm1145.
10
Evolution of ciprofloxacin-resistant Staphylococcus aureus in in vitro pharmacokinetic environments.环丙沙星耐药金黄色葡萄球菌在体外药代动力学环境中的演变。
Antimicrob Agents Chemother. 2004 Dec;48(12):4733-44. doi: 10.1128/AAC.48.12.4733-4744.2004.